A multicentre retrospective analysis on pentostatin as salvage therapy of severe steroid refractory acute graft-versus-host disease of the gastro-intestinal tract

被引：0
|
作者：
Klein, S. A.
Schmitt, T.
Bug, G.
Schetelig, J.
Schwerdtfeger, R.
Schaefer-Eckart, K.
Schmid, C.
Kobbe, G.
Heidenreich, D.
Bornhaeuser, M.
Martin, H.
Dreger, P.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S150 / S150
页数：1
相关论文
共 50 条
  • [31] Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis
    Tobias Wertheimer
    Marius Dohse
    Gabriel Afram
    Daniela Weber
    Martin Heidenreich
    Barbara Holler
    Anna-Sophia Kattner
    Andreas Neubauer
    Stephan Mielke
    Per Ljungman
    Ernst Holler
    Wolfgang Herr
    Matthias Edinger
    Antonio Pérez Martínez
    Matthias Fante
    Daniel Wolff
    Annals of Hematology, 2021, 100 : 779 - 787
  • [32] Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis
    Fante, Matthias A.
    Holler, Barbara
    Weber, Daniela
    Angstwurm, Klemens
    Bergler, Tobias
    Holler, Ernst
    Edinger, Matthias
    Herr, Wolfgang
    Wertheimer, Tobias
    Wolff, Daniel
    ANNALS OF HEMATOLOGY, 2020, 99 (09) : 2181 - 2190
  • [33] Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis
    Matthias A. Fante
    Barbara Holler
    Daniela Weber
    Klemens Angstwurm
    Tobias Bergler
    Ernst Holler
    Matthias Edinger
    Wolfgang Herr
    Tobias Wertheimer
    Daniel Wolff
    Annals of Hematology, 2020, 99 : 2181 - 2190
  • [34] Rituximab as salvage therapy for refractory chronic graft-versus-host disease
    Mohty, M.
    Marchetti, N.
    El-Cheikh, J.
    Faucher, C.
    Fuerst, S.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S231 - S231
  • [35] Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
    Liu, Jiapei
    Fan, Zhiping
    Xu, Na
    Ye, Jieyu
    Chen, Yanqiu
    Shao, Ruoyang
    Sun, Yiming
    Wu, Qiaoyuan
    Liu, Qifa
    Jin, Hua
    ANNALS OF HEMATOLOGY, 2023, 102 (10) : 2865 - 2877
  • [36] Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
    Jiapei Liu
    Zhiping Fan
    Na Xu
    Jieyu Ye
    Yanqiu Chen
    Ruoyang Shao
    Yiming Sun
    Qiaoyuan Wu
    Qifa Liu
    Hua Jin
    Annals of Hematology, 2023, 102 : 2865 - 2877
  • [37] Infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease.
    Patriarca, F
    Sperotto, A
    Prosdocimo, S
    Skert, C
    Morreale, G
    Dini, G
    Bandini, G
    Milone, G
    Corradini, P
    Peccatori, J
    Fanin, R
    Bosi, A
    Bacigalupo, A
    BLOOD, 2003, 102 (11) : 451B - 451B
  • [38] Ruxolitinib for steroid-refractory acute graft-versus-host disease
    Toama, Wael
    Fiala, Mark
    Pusic, Iskra
    Westervelt, Peter
    Dipersio, John F.
    Schroeder, Mark
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
  • [39] Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Jan, Anna
    Shigle, Terri Lynn
    Wang, Emily
    Nieto, Yago
    Ciurea, Stefan O.
    Oran, Betul
    Im, Jin
    Olson, Amanda
    Marin, David
    Qazilbash, Muzaffar
    Khouri, Issa
    Rondon, Gabriela
    Anderlini, Paolo
    Rezvani, Katayoun
    Popat, Uday
    Kebriaei, Partow
    Shpall, Elizabeth
    Champlin, Richard
    Alousi, Amin
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 272.e1 - 272.e5
  • [40] Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis
    Wertheimer, Tobias
    Dohse, Marius
    Afram, Gabriel
    Weber, Daniela
    Heidenreich, Martin
    Holler, Barbara
    Kattner, Anna-Sophia
    Neubauer, Andreas
    Mielke, Stephan
    Ljungman, Per
    Holler, Ernst
    Herr, Wolfgang
    Edinger, Matthias
    Martinez, Antonio Perez
    Fante, Matthias
    Wolff, Daniel
    ANNALS OF HEMATOLOGY, 2021, 100 (03) : 779 - 787
12345